GI
IRMD icon

GAMMA Investing’s iRadimed IRMD Stock Holding History

GAMMA Investing’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.01K Buy
42
+2
+5% +$182 ﹤0.01% 3565
2026
Q1 		$3.85K Buy
40
+7
+21% +$700 ﹤0.01% 3463
2025
Q4 		$3.21K Hold
33
– – ﹤0.01% 3451
2025
Q3 		$2.35K Hold
33
– – ﹤0.01% 3410
2025
Q2 		$1.97K Buy
33
+26
+371% +$1.43K ﹤0.01% 3408
2025
Q1 		$367 Buy
7
+6
+600% +$337 ﹤0.01% 3713
2024
Q4 		$55 Buy
+1
New +$53 ﹤0.01% 3761

Other funds holding IRMD

SI
Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
KPP
Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return

GAMMA Investing's IRMD Position: Q2 2026 in Review

GAMMA Investing increased its iRadimed (IRMD) stake by 5% in Q2 2026, buying an estimated $182 and bringing the position to 42 shares worth $4.01K. The position accounts for ﹤0.01% of the portfolio, ranked #3565.

GAMMA Investing first reported a position in IRMD in Q4 2024 and has held it in 7 quarters since. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • GAMMA Investing held 42 shares of iRadimed worth $4.01K as of Q2 2026.
  • GAMMA Investing bought 2 iRadimed shares in Q2 2026, an estimated $182.
  • iRadimed made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3565 holding.
  • GAMMA Investing first reported a position in iRadimed in Q4 2024 and has held it in 7 quarters since.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.